Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Switching REMS Vendors: AAM Calls For FDA Guidance On Performance Standards
Jul 26 2023
•
By
Brenda Sandburg
The FDA gets advice on dealing with changes in vendors administering Risk Evaluation and Mitigation Strategies. • Source: Shutterstock
More from Drug Safety
More from Pink Sheet